In a meta-analysis, data from multiple studies is pooled in order to build a more substantial basis for comparative and statistical assessment.
As published in the Journal of the American Medical Directors Association, a meta-analysis was recently completed using six clinical trials intended to compare curcumin (from turmeric) to a placebo in a total of 377 patients suffering from depression.
The results supported a significant clinical effectiveness of curcumin in terms of depression relief. Furthermore, it was noted that no adverse affects whatsoever were reported during the trials. The authors of the meta-study recommend more comprehensive trials encompassing greater numbers of depression patients and spanning longer time periods.
Read the entire article here: